Metastatic Medullary Thyroid Cancer

Also known as: Thyroid cancer metastases / Thyroid cancer metastatic / Metastatic thyroid malignancy / Metastatic Thyroid Cancer

DrugDrug NameDrug Description
DB09293Iodide I-131A radioisotopic agent used for the treatment of hyperthyroidism and thyroid carcinomas that take up iodine.
DB05294VandetanibAn antineoplastic kinase inhibitor used to treat symptomatic or progressive medullary thyroid cancer in patients with unresectable locally advanced or metastatic disease.
DrugDrug NamePhaseStatusCount
DB00041Aldesleukin1 / 2Withdrawn1
DB00531Cyclophosphamide1 / 2Withdrawn1
DB01073Fludarabine1 / 2Withdrawn1
DB01584Thyroglobulin1 / 2Withdrawn1
DB00945Acetylsalicylic acid2Completed1
DB00531Cyclophosphamide2Recruiting1
DB06643Denosumab2Recruiting1
DB11714Durvalumab2Recruiting1
DB09078Lenvatinib2Recruiting1
DB00877Sirolimus2Recruiting1
DB00398Sorafenib2Completed1
DB11771Tremelimumab2Recruiting1
DB06215FerumoxytolNot AvailableSuspended1
DB01592IronNot AvailableSuspended1